Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs Sahara AI (SAHARA) Price & Performance

Price performance (Past 24H)

Key statistics

Enzyme vs Sahara AI — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Sahara AI trades at Rp138.4 (market cap Rp495,33M, Rp87,85M 24h volume). The key difference: Sahara AI is far larger — about 3.7× Enzyme's market cap, and Sahara AI's supply is capped (3,6B / 10B SAHARA (36%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Sahara AI for 14 Days on average.

MLNSAHARA
Market Cap
Rp134,13MRp495,33M
Volume (24h)
Rp104,56MRp87,85M
Circulating Supply
3,3M MLN3,6B / 10B SAHARA (36%)
Typical Hold Time
29 Days14 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Sahara AI

Sahara AI is trading at Rp139.81 with a bearish technical signal, as indicated by moving averages. The token is near its pivot point of Rp140, with support at Rp138 and resistance at Rp142. With a market cap of Rp499.73M and 36% of its 10M max supply in circulation, the asset shows limited network expansion. No recent protocol updates or significant ecosystem developments were noted.

Overall outlook is cautious due to strong bearish technicals and low liquidity. Key opportunities include potential rebounds from oversold RSI levels, but major risks involve high volatility, low trading volume, and absence of recent fundamental catalysts. Investors should monitor for any new network activity or exchange listings.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MLN

No sentiment data available yet.

SAHARA
23% Buy77% Sell
Avg holding period · 14 Days

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About Sahara AI

Sahara AI is the first comprehensive AI-native blockchain platform that allows anyone to create, contribute to, and monetize AI development, promoting accessibility and equity in the AI field. Based on the Sahara blockchain, it features a Data Services Platform for data labeling, an AI Developer Platform for model creation and deployment, and a decentralized AI Marketplace for buying and selling datasets, models, agents, and computing resources.

Read more on SAHARA